Molecular Formula：
C82H103ClN18O16
Relative Molecular Mass：
1632.28 g/mol
CAS-Number：
214766-78-6 (net)
Long-term Storage：
-20 ± 15°C
Synonym：
FE200486
Sequence：
Ac-D-2-Nal-D-4-Cpa-D-3-Pal-Ser-4-amino-Phe(L-hydroorotyl)-4-ureido-
D-Phe-Leu-Lys(isopropyl)-Pro-D-Ala-NH2 acetate salt
Fields of Application：
Advanced hormone-dependent prostate carcinoma
Active Substance：
Degarelix Acetate is an LHRH (GnRH) receptor antagonist, indicated for patients with advanced prostate cancer. Degarelix reversibly and dose-dependently suppresses gonadotropin and sex steroid levels by inhibiting the binding of endogenous LHRH to its receptors.
Degarelix showed to be at least as effective as leuprolide in sustaining levels of testosterone that are equivalent to or lower than that seen with castration.
Main product
Peptide APIs: Oxytocin Acetate,Vasopressin Acetate,Desmopressin Acetate,Terlipressin acetate, Caspofungin acetate, Micafungin sodium, Eptifibatide acetate, Bivalirudin TFA, Deslorelin Acetate,Glucagon Acetate,Histrelin Acetate,Liraglutide Acetate,Linaclotide Aceteate ,Degarelix Acetate,Buserelin Acetate,Cetrorelix Acetate,Goserelin Acetate.
Cosmetic peptide: Argireline Acetate, Metrixyl Acetate,Snap-8,.....
The process of these products is very mature and stable which let us have the ability to provide you with prompt response, better price and speedy delivery. And help you in selecting the right protection for your application.
Company Profile
Company: Shenzhen JYMed Technology Co., Ltd
Found in 2009, our peptide plant is located in Nanjing, Jiangsu province and it has set up a facility of 30,000 square meters in compliance with cGMP guideline. The manufacture facility has been audited and inspected by both domestic and international clients.
Contact
June Kang
Email: june@jymedtech.com
Tel: 86-0755-86350931
QQ: 821653780
深圳市健元醫(yī)藥科技有限公司是一家專業(yè)從事多肽系列產(chǎn)品研究開發(fā)和生產(chǎn)銷售的高新技術(shù)企業(yè)。主要產(chǎn)品包括多肽原料藥、美容多肽、獸用多肽、客戶定制肽等。
健元醫(yī)藥始終秉持“求實創(chuàng)新”的企業(yè)精神，在產(chǎn)品的研發(fā)上精益求精，組建了一支規(guī)模超過50人的專業(yè)化研發(fā)團隊；現(xiàn)擁有涉及多肽系列產(chǎn)品的發(fā)明專利26項，其中7項專利已授權(quán)，PCT專利1項，進入實審狀態(tài)的發(fā)明專利18項。
健元醫(yī)藥研發(fā)中心位于深圳市高新技術(shù)產(chǎn)業(yè)園內(nèi)，配備有國際先進的多肽產(chǎn)品研發(fā)儀器設(shè)備，生產(chǎn)基地位于南京市溧水經(jīng)濟開發(fā)區(qū)星銀醫(yī)藥園內(nèi)。工廠嚴格按照GMP要求進行生產(chǎn)和質(zhì)量管理，可以為客戶生產(chǎn)和供應(yīng)符合cGMP要求的多肽系列產(chǎn)品。
健元醫(yī)藥以其優(yōu)質(zhì)的多肽產(chǎn)品，強大